Pneumonia Clinical Trials

A listing of Pneumonia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1282 clinical trials
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Purpose of Study The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.

chest x-ray
covid-19
coronavirus infection
acute respiratory syndrome (sars)
d-dimer
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Prone Positioning for Patients on General Medical Wards With COVID19

COVID-PRONE is a multicenter, pragmatic, single-blind, 2-arm, parallel, randomized controlled trial seeking to compare the pre-emptive prone positioning (i.e. encouraging patients to adopt a prone position before they require mechanical ventilation) to the control arm of standard care alone. Randomization will be stratified by site.

covid-19
mechanical ventilation
nosocomial infection
fraction of inspired oxygen (fio2)
FIO2
  • 0 views
  • 19 Feb, 2024
  • 7 locations
Study for Novel Coronavirus Pneumonia (NCP)

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Understanding Immunity to SARS-CoV-2 the Coronavirus Causing COVID-19

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

covid-19
acute respiratory syndrome (sars)
pneumonia
coronavirus infection
SARS
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prediction of Clinical Course in COVID19 Patients

In the context of the COVID19 pandemic and containment, chest CT is currently frequently performed on admission, looking for suggestive signs and basic abnormalities of COVID19 compatible viral pneumonitis pending confirmation of identification of viral RNA by reverse-transcription polymerase chain reaction(PCR), with a reported sensitivity of 56-88% in the first …

PCR test
ct scan
chest ct
lung disease
pneumonia
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Longitudinal Study of COVID-19 Sequelae and Immunity

Some people who get COVID-19 have only mild symptoms. But for others, infection leads to pneumonia, respiratory failure, and, in some cases, death. Researchers want to learn more about any effects that may persist after people recover from COVID-19.

chest x-ray
acute respiratory syndrome (sars)
nasal swab
asymptomatic infection
white blood cell count
  • 0 views
  • 19 Feb, 2024
  • 1 location
Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients

Previous studies claims that the proportion of mean platellet volume to platellet which can simply be determined with simple blood tests that are performed at admission, might predict the mortality in ARDS patients. Covid-19 pneumonia has a very similar clinical outlook with ARDS. Therefore we decided to research whether that …

covid-19
acute respiratory distress
pneumonia
acute respiratory distress syndrome
blood test
  • 0 views
  • 19 Feb, 2024
  • 1 location
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of COVID-19 pneumonia.

covid-19
acute respiratory syndrome (sars)
SARS
pneumonia
antiviral drugs
  • 0 views
  • 19 Feb, 2024
  • 1 location
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

In December 2019, a pneumonia due to a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, in China. In a few weeks, the number of confirmed cases of SARS-CoV-2 infection has dramatically increased, with almost 150'000 cases and more than 6'000 reported deaths on March, 16th 2020.

covid-19
acute respiratory syndrome (sars)
pneumonia
coronavirus infection
SARS
  • 0 views
  • 19 Feb, 2024
  • 17 locations
Development of a Simple Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV

In late December 2019, several local health facilities reported clusters of patients with pneumonia of unknown cause that were epidemiologically linked to a seafood and wet animal wholesale market in Wuhan, Hubei Province, China.

  • 0 views
  • 19 Feb, 2024
  • 1 location